Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Early-stage investor Syncona readjusts priorities due to bleak biotech market
3 weeks ago
Financing
Startups
FDA OKs new label expansions for Dupixent and Incyte's Monjuvi
3 weeks ago
News Briefing
Enzene, Veranova separately unveil expansions; Lotte's new ADC client
3 weeks ago
Manufacturing
Roche's venture arm chief to step down in 2026; AstraZeneca obesity leader has retired
3 weeks ago
Peer Review
FDA's top cell and gene therapy leaders exit agency in ongoing CBER changes
3 weeks ago
Cell/Gene Tx
FDA+
Grail shares jump on study results for cancer test
3 weeks ago
Pharma
Diagnostics
Gilead gets groundbreaking FDA approval for twice-yearly HIV prevention shot
3 weeks ago
Pharma
FDA+
Compounders lose case over semaglutide shortage
3 weeks ago
Pharma
Health Tech
Zealand study shows higher GLP-1/GLP-2 doses may lead to greater weight loss
3 weeks ago
R&D
CBER head Prasad adds chief medical and scientific officer to his title
3 weeks ago
Pharma
FDA+
Q&A: New BIO chair to steer industry through ‘existential threats’ despite FDA receptivity
3 weeks ago
R&D
China
BioNTech stops making cell therapy at Maryland site after dropping germ cell tumor indication
4 weeks ago
R&D
Cell/Gene Tx
How a tailored ALS drug could help broaden rare disease therapies
4 weeks ago
R&D
Discovery
Scholar Rock’s muscle-preserving obesity drug add-on looks competitive
4 weeks ago
R&D
Tennr raises $101M Series C to fix faxes with AI
4 weeks ago
Financing
Health Tech
Humana details plans to grow its primary care business as competing clinics shutter
4 weeks ago
Deals
Health Tech
Bavarian Nordic's PRV goes for $160M; Biomea to advance GLP-1 into trials
4 weeks ago
News Briefing
Watch Post-Hoc Live: China is still the top conversation starter at BIO
4 weeks ago
Editor's note
China
Actio gets $66M for experimental epilepsy and Charcot-Marie-Tooth treatments
4 weeks ago
Financing
Sanofi-backed Welsh biotech secures $140M for neuropsychiatry pipeline
4 weeks ago
Financing
Startups
Members of Congress oppose NIH's payment cut plan, urge appeals court to maintain block
4 weeks ago
Law
Orphan drug, PBM changes are excluded from Senate version of Trump tax bill
4 weeks ago
Pharma
Law
FDA approves CSL’s prophylactic for severe swelling condition
4 weeks ago
Pharma
FDA+
FDA unveils one-year pilot to speed some new drugs to market in just one month
4 weeks ago
FDA+
First page
Previous page
5
6
7
8
9
10
11
Next page
Last page
